EI
DNTH icon

Ellevest Inc’s Dianthus Therapeutics DNTH Stock Holding History

Ellevest Inc’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed – – 1456
2022
Q1 		$0 Buy
+3
New +$164 ﹤0.01% 1468
2021
Q3 		– Sell
-3
Closed – – 1445
2021
Q2 		$0 Buy
3
+2
+200% +$367 ﹤0.01% 1301
2021
Q1 		$0 Hold
1
– – ﹤0.01% 1278
2020
Q4 		$0 Sell
1
-4
-80% -$454 ﹤0.01% 1227
2020
Q3 		$1K Buy
+5
New +$592 ﹤0.01% 989

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return